Lisa Scherer

This inventor holds 1 USPTO granted patent. Top assignee: Beckman Research Institute, City of Hope. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa Scherer. Retrieved from https://idiyas.com/inventor/lisa-scherer-vwcpepw9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lisa Scherer: Innovator in Cancer Treatment

Introduction

Lisa Scherer is a prominent inventor known for her significant contributions to the field of cancer treatment. She is particularly recognized for her innovative work in developing therapies for acute myeloid leukemia. With a strong academic background and a passion for research, Lisa has made strides in the medical community.

Latest Patents

Lisa holds a patent titled "Conditional-siRNAs and Uses Thereof in Treating Acute Myeloid Leukemia." This patent represents her commitment to advancing treatment options for patients suffering from this challenging disease. Her work has the potential to improve patient outcomes and provide new avenues for therapy.

Career Highlights

Lisa Scherer is affiliated with City of Hope, a leading research and treatment center. Her role at this institution allows her to collaborate with other experts in the field and contribute to groundbreaking research. With her dedication and expertise, she has become a valuable asset to her team.

Collaborations

Throughout her career, Lisa has worked alongside esteemed colleagues such as Guido Marcucci and Ya-Huei Kuo. These collaborations have fostered an environment of innovation and have led to significant advancements in cancer research.

Conclusion

In summary, Lisa Scherer is an influential inventor whose work in cancer treatment is making a difference in the lives of many. Her dedication to research and collaboration with other experts highlights her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…